Inhibition of EZH2 could suppress oral squamous cell carcinoma (OSCC) progression via modulate EZH2/Wnt/beta-catenin pathway, both in vitro and in vivo (44). The gene discussed is EZH2; the disease is oral cavity squamous cell carcinoma.